Computational exploration of the dual role of the phytochemical fortunellin: Antiviral activities against SARS-CoV-2 and immunomodulatory abilities against the hostArticle Published on 2022-10-012022-11-15 Journal: Computers in biology and medicine [Category] COVID19(2023년), SARS, 유전자 메커니즘, 치료제, [키워드] activity acute respiratory syndrome analyses Analysis Antiviral antiviral activity apoptosis pathway approach bind binding site Colon coronavirus disease Coronavirus-2 COVID-19 COVID-19 patients effective endoribonuclease enrichment enrichment analysis evaluate Fortunellin generate Genetic growth Host identify immunomodulation immunomodulatory immunomodulatory capability Infection inherent inhibiting Invasion liver lung cell majority mechanism MM-GBSA analysis molecular molecular docking molecular dynamics Molecular dynamics simulation Multi-target mutability network network pharmacology NHBE Ontology Organoid pancreatic pathway per day pro-inflammatory cytokine protective immunity protein-protein interaction SARS-CoV-2 Support target target proteins targets the SARS-CoV-2 therapeutic tissue damage tissues treating COVID-19 viral replication virion virus [DOI] 10.1016/j.compbiomed.2022.106049 PMC 바로가기
Ursolic acid and SARS-CoV-2 infection: a new horizon and perspectiveArticle Published on 2022-10-012022-11-15 Journal: Inflammopharmacology [Category] COVID19(2023년), SARS, 치료제, [키워드] acute lung injury acute respiratory distress acute respiratory syndrome Anti-inflammatory anti-inflammatory cytokines antioxidant antioxidant effects Antiviral ARDS Complication complications coronavirus COVID-19 Cytokine storm disease-causing disorders dysregulation hyper inflammation immune response Immunity IMPROVE indirect effect inflammatory signaling inhibit lung manifestation mitigate neurological oxidative stress pandemic Pandemics Pathways Perspective pro-inflammatory cytokine pro-inflammatory cytokines progression RAS reactive oxygen specy reduce renin-angiotensin system ROS SARS-CoV-2 SARS-COV-2 infection severe cases syndrome ursolic acid Viral pneumonia [DOI] 10.1007/s10787-022-01038-3 PMC 바로가기
Prophylactic treatment of Glycyrrhiza glabra mitigates COVID-19 pathology through inhibition of pro-inflammatory cytokines in the hamster model and NETosisArticle Published on 2022-09-272022-11-16 Journal: Frontiers in Immunology [Category] SARS, 변종, [키워드] accompanied acute respiratory distress addition Comorbidity coronavirus disease COVID-19 COVID-19 pathology cytokine production decrease dysregulated immune response effective Efficacy Evidence functions glycyrrhiza Glycyrrhiza glabra Hamster model hamsters hypercoagulable IL-17A IL-4 immunocompromised individuals immunomodulator immunomodulatory properties Inflammatory cytokine ingredient Lung pathology lung viral load mice mice and human neutrophil functions. mitigate Mortality mRNA expression murine NET NETosis neutrophil polymorphonuclear neutrophil pro-inflammatory cytokine Protective provide Pulmonary pathology reduced reducing robust ROS SARS-CoV-2 SARS-COV-2 infection skewed suppress syndrome Th17 Th2 Th2/Th17 differentiation Treatment vaccination Vaccine variant [DOI] 10.3389/fimmu.2022.945583 PMC 바로가기
SARS-CoV-2 modulates virus receptor expression in placenta and can induce trophoblast fusion, inflammation and endothelial permeabilityArticle Published on 2022-09-132022-11-16 Journal: Frontiers in Immunology [Category] SARS, 유전자 메커니즘, [키워드] ACE2 addition Apoptosis CD147 Cell cell lines cells Coagulation complement Cytokine storm Effect elevated elicit endothelial event Evidence expression fetal Hyperactivation immunopathological Impact incidence increased vascular permeability induce infected with SARS-CoV-2 Infection Inflammation less main receptor mechanism modulate Mortality mother outcomes pathway Placenta placental positive Pregnancy pregnant Preterm birth pro-inflammatory cytokine Protein raise SARS-CoV-2 spike susceptibility syndrome the SARS-CoV-2 TMPRSS2 TMPRSS2 expression Transmission upregulated virus virus receptor [DOI] 10.3389/fimmu.2022.957224 PMC 바로가기
Intranasal administration of a single dose of MVA-based vaccine candidates against COVID-19 induced local and systemic immune responses and protects mice from a lethal SARS-CoV-2 infectionArticle Published on 2022-09-122022-11-15 Journal: Frontiers in Immunology [Category] SARS, 변종, 진단, 치료기술, [키워드] absence acute respiratory syndrome Administered administration animal model blocked bronchoalveolar C57BL/6 caused CD4 CD8 coronavirus Coronavirus disease-19 COVID-19 COVID-19 progression current demonstrated effective Efficacy elicited evaluated expressing full-length histopathological IgA antibody IgG immune responses Immunity immunogenic immunogenicity induce intramuscular intranasal intranasal delivery K18-hACE2 transgenic mice Local lung lung lesion lymph nodes mice modified vaccinia virus morbidity and mortality mucosal mucosal immune MVA nasal washe Nasal washes neutralizing antibody parental Prevent pro-inflammatory cytokine PROTECT Protective protective efficacy Protein responses Result S protein SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 transmission SARS-CoV-2 variant SARS-CoV-2 virus SARS-CoV-2-specific immune response serum single dose spleen susceptible systemic immune response systemically T-cell immune response the SARS-CoV-2 Transmission undetectable upper respiratory tract vaccination Vaccine vaccine administration vaccine candidate vaccine candidates vaccine dose virus infection [DOI] 10.3389/fimmu.2022.995235 PMC 바로가기
Autoantibodies elicited with SARS-CoV-2 infection are linked to alterations in double negative B cellsArticle Published on 2022-09-052022-11-15 Journal: Frontiers in Immunology [Category] SARS, 진단, [키워드] Activation alteration antibodies autoantibodies autoantibody Autoimmune disease autoreactive autoreactive antibody B cell B cells BCR Cell changes in characterized CRP described DN1 DN2 DN3 DN3 cells DN4 double negative elevated elicited Frequency functional heterogenous IFNγ IL-1β IL-6 Immunoglobulin increase increase in Infection Inflammation interferon negative precursor pro-inflammatory cytokine reduction in reported SARS-COV-2 infection SARS–CoV–2 secreting cell serum Severe infection severe SARS-CoV-2 Signaling significantly subset systemic inflammation systemic level TNFα viral infection [DOI] 10.3389/fimmu.2022.988125 PMC 바로가기
Infliximab in the treatment of patients with severe COVID-19 (INFLIXCOVID): protocol for a randomised, controlled, multicentre, open-label phase II clinical studyArticle Published on 2022-09-022022-10-04 Journal: Trials [Category] SARS, 임상, 진단, [키워드] 28-day mortality addition Affect Alpha approved assessment Blood changes chronic inflammatory disease clinical study clinical trial collected Course COVID-19 current therapy dose driven by Effectiveness ethics committee EudraCT Friedrich Schiller high mortality hyperinflammation IL-6 IMPROVE infections Infectious diseases infliximab International Laboratory molecular molecular diagnostics monoclonal antibody morbidity multicentre Open-label Patient patients with COVID-19 primary endpoint pro-inflammatory cytokine protocol randomised randomised controlled trial receive Registered Research respiratory respiratory infections resulting severe COVID-19 Standard of care systemic inflammatory the disease therapy TNF-α Treatment Trial university Urine [DOI] 10.1186/s13063-022-06566-5 PMC 바로가기 [Article Type] Article
Mesenchymal stem cell treatment for hyperactive immune response in patients with COVID-19COVID-19 환자의 과민성 면역 반응을 위한 중간엽 줄기세포 치료Review Published on 2022-09-012022-09-11 Journal: Immunotherapy [Category] COVID19(2023년), SARS, 변종, [키워드] Biomarker Biomarkers clinical clinical immunology clinical trials COVID-19 COVID-19 mortality COVID-19 patients CRP Cytokines decrease Effect effective Endothelitis epithelial cells Human immune system IL-6 immune response immune system independent invasive mesenchymal stem cell Mesenchymal stem cells MSC MSC therapy MSCs organism patients with COVID-19 potential treatment option pro-inflammatory cytokine pro-inflammatory cytokines PROTECT reduction in regenerative regimen reported Respiratory failure Safe sick stem cell stem cells systemic systemic effects therapy Treatment Trial [DOI] 10.2217/imt-2021-0245 PMC 바로가기 [Article Type] Review
Immune modulation as a consequence of SARS-CoV-2 infectionArticle Published on 2022-08-302022-11-15 Journal: Frontiers in Immunology [Category] SARS, 진단, 치료기술, [키워드] adaptive Alter alteration B cells CD3 CD8 Clinical severity clinically COVID-19 COVID-19 pathogenesis Cytokine storm D-dimer levels Decreased detrimental effects diagnosed elevated Elevation enrolled Frame healthy controls IFN-γ IgA level IgG IL-10 IL-6 IL-8 ILCs immune immune response Immunity Mild moderate modulated modulation negative correlation NK cell NK cells Patient Plasma cell pro-inflammatory cytokine Protective reduced reduction SARS-CoV-2 SARS-COV-2 infection Serum level severe COVID-19 disease Severe patient severe patients significantly subset T cell T cells the disease TNF-α [DOI] 10.3389/fimmu.2022.954391 PMC 바로가기
SARS-CoV-2 Delta variant induces enhanced pathology and inflammatory responses in K18-hACE2 miceArticle Published on 2022-08-292022-11-15 Journal: PLoS ONE [Category] SARS, 변종, 치료제, [키워드] activated Analysis Beta Brain Cell challenge COVID-19 COVID-19 pandemic Delta delta variant Delta VOC Differential gene expression disease dose engage ENhance evaluate experiment Gene Expression highest histopathological host response IFN-γ in silico in vivo induce infiltration Inflammation Inflammatory response interferon response K18-hACE2 mice lung lung tissue magnitude mice nasal no significant difference observation Pathogenesis pathology Pneumonia pro-inflammatory cytokine qRT-PCR analysis Receptor binding RNA-sequencing SARS-CoV-2 strain Strains suggested T-cell TCR Total Transmissibility unique Vaccines variants of concern Viral RNA VoC was performed [DOI] 10.1371/journal.pone.0273430 PMC 바로가기